Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anxiety, Depression Compromise Believability of Drug-Allergy Testing

Publish date:: March 8, 2019

Key clinical point: Patients with anxiety or depression were more likely to doubt a negative drug-allergy test result.

Major finding: Skepticism about a negative drug-allergy result came from 24% of people with anxiety, 20% with depression, and 7% with neither.

Study details: A prospective study of 100 people at the drug-allergy clinic of one U.S. center.

Disclosures: Dr. Rukasin had no relevant financial disclosures.

Citation:

Rukasin C et al. J Allergy Clin Immunol. 2019 Feb;143(2):AB428.

This Week's Must Reads

Pimavanserin reduced dementia-related psychotic symptoms without affecting cognition,

Schizophrenia, Autistic Traits Tied to More Theory of Mind Impairments,

ECT Surpasses Other Treatments in Refractory Schizophrenia,

Adjunctive Yoga Tied to Improvements in Adults With Schizophrenia,

Revised Schizophrenia Quality of Life Scale Found Highly Sensitive,

Must Reads in Anxiety Disorders

Higher risk of bipolar disorder, depression, anxiety found with autism,

Conduct disorder in girls gets overdue research attention,

Fluoxetine Tied to Lower Obsessive-Compulsive Scores Among Children With ASDs,

Early maternal anxiety tied to adolescent hyperactivity,

Internet-Delivered Intervention Eases Depression Symptoms,

Menu Close